A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Journal of Clinical Investigation

• Publication date

  1998-06-15

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1172/JCI1325PMID 9637713PMCID PMC508870
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The proto-oncogene Bcl-2 and its role in regulating apoptosis

  1997influential reference
• Nuclear DNA fragmentation and expression of Bcl‐2 in primary biliary cirrhosis

  1997cited by this paper
• Expression of Apoptosis-Regulatory Genes in Renal Proximal Tubular Epithelial Cells Exposed to High Ambient Glucose and in Diabetic Kidneys

  1997cited by this paper
• Double identity for proteins of the Bcl-2 family

  1997cited by this paper
• Cathepsin B contributes to bile salt-induced apoptosis of rat hepatocytes.

  1997cited by this paper
• Mitochondrial control of apoptosis.

  1997cited by this paper
• Bile salt-induced apoptosis of hepatocytes involves activation of protein kinase C.

  1997cited by this paper
• Inhibition of bile-salt-induced hepatocyte apoptosis by the antioxidant lazaroid U83836E.

  1997cited by this paper
• The retinoblastoma gene product inhibits TGF-beta1 induced apoptosis in primary rat hepatocytes and human HuH-7 hepatoma cells.

  1996influential reference
• Metabolism of orally administered tauroursodeoxycholic acid in patients with primary biliary cirrhosis.

  1996cited by this paper
• Specific cleavage of the retinoblastoma protein by an ICE‐like protease in apoptosis.

  1996cited by this paper
• The role of proteases during apoptosis

  1996cited by this paper
• Posttranscriptional regulation of mRNA levels in rat liver associated with deoxycholic acid feeding.

  1995cited by this paper
• The biochemistry of programmed cell death

  1995cited by this paper
• Apoptosis and hepatobiliary disease

  1995cited by this paper
• Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death

  1995cited by this paper
• Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo

  1995cited by this paper
• Apoptosis in the pathogenesis and treatment of disease

  1995cited by this paper
• The Fas death factor

  1995cited by this paper
• Alteration of cAMP-mediated hormonal responsiveness by bile acids in cells of nonhepatic origin.

  1995cited by this paper
• Cell death: Current difficulties in discriminating apoptosis from necrosis in the context of pathological processes in vivo

  1995cited by this paper
• Ursodeoxycholate (UDCA) inhibits the mitochondrial membrane permeability transition induced by glycochenodeoxycholate: a mechanism of UDCA cytoprotection.

  1995influential reference
• Nuclear serine protease activity contributes to bile acid-induced apoptosis in hepatocytes.

  1995cited by this paper
• Ursodiol for the long-term treatment of primary biliary cirrhosis. The UDCA-PBC Study Group.

  1994cited by this paper
• Programmed cell death and Bcl‐2 protection in the absence of a nucleus.

  1994cited by this paper
• Cell nucleus and DNA fragmentation are not required for apoptosis

  1994cited by this paper
• Intracellular hydrogen peroxide and superoxide anion detection in endothelial cells

  1994cited by this paper
• Chemoprevention of azoxymethane-induced colonic carcinogenesis by supplemental dietary ursodeoxycholic acid.

  1994cited by this paper
• Increases of intracellular magnesium promote glycodeoxycholate-induced apoptosis in rat hepatocytes.

  1994influential reference
• Ursodeoxycholate conjugates protect against disruption of cholesterol-rich membranes by bile salts.

  1994cited by this paper
• Hepatocyte apoptosis: is transforming growth factor-B1 the kiss of death?

  1993cited by this paper
• Hepatocellular Transport of Bile Acids

  1993cited by this paper
• Detection of the initial stages of DNA fragmentation in apoptosis.

  1993cited by this paper
• Lethal effect of the anti-Fas antibody in mice

  1993cited by this paper
• Glycochenodeoxycholate-induced lethal hepatocellular injury in rat hepatocytes. Role of ATP depletion and cytosolic free calcium.

  1993cited by this paper
• Cyclosporin and carnitine prevent the anoxic death of cultured hepatocytes by inhibiting the mitochondrial permeability transition.

  1993cited by this paper
• Apoptotic bodies in a murine model of alcoholic liver disease: Reversibility of ethanol‐induced changes

  1993cited by this paper
• Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor beta 1.

  1992cited by this paper
• The role of the matrix calcium level in the enhancement of mitochondrial pyruvate carboxylation by glucagon pretreatment.

  1992cited by this paper
• Conjugates of ursodeoxycholate protect against cholestasis and hepatocellular necrosis caused by more hydrophobic bile salts. In vivo studies in the rat.

  1991cited by this paper
• Activation of mast cells by bile acids.

  1991influential reference
• Bile salt/acid induction of DNA damage in bacterial and mammalian cells: implications for colon cancer.

  1991cited by this paper
• Ursodeoxycholic acid for primary sclerosing cholangitis.

  1990cited by this paper
• Hepatic injury induced by bile salts: Correlation between biochemical and morphological events

  1990cited by this paper
• Effects of ursodeoxycholic acid and taurine on serum liver enzymes and bile acids in chronic hepatitis.

  1990cited by this paper
• Mechanisms by which mitochondria transport calcium.

  1990cited by this paper
• Oxidant injury to hepatic mitochondrial lipids in rats with dietary copper overload. Modification by vitamin E deficiency.

  1990cited by this paper
• Subcellular changes and apoptosis induced by ethanol in rat liver.

  1988cited by this paper
• Rapid synergistic interaction between thyroid hormone and carbohydrate on mRNAS14 induction.

  1986cited by this paper
• Ursodeoxycholic acid treatment of bile reflux gastritis.

  1985cited by this paper
• Mass spectrometry of bile acids.

  1985cited by this paper
• Detection of picomole levels of hydroperoxides using a fluorescent dichlorofluorescein assay.

  1983cited by this paper
• Cell death: the significance of apoptosis.

  1980cited by this paper

• Optimal Cannabinoid-Terpene Combination Ratios Suppress Mutagenicity of Gastric Reflux in Normal and Metaplastic Esophageal Cells

  2025cites this paper
• Ursodeoxycholic acid ameliorates paclitaxel-induced hepatic injury in rats: Evaluation of oxidative and DNA damage, apoptosis and autophagy.

  2025cites this paper
• Bile Acid-conjugate as a Promising Anticancer Agent: Recent Progress.

  2024cites this paper
• UDCA for Drug-Induced Liver Disease: Clinical and Pathophysiological Basis

  2024cites this paper
• How bile acids and the microbiota interact to shape host immunity

  2024influential citation
• Critical role of endoplasmic reticulum stress on bisphenol A‐induced cytotoxicity in human keratinocyte HaCaT cells

  2024cites this paper
• Ursodeoxycholic acid

  2023cites this paper
• Bile acids as signaling molecules: Role of ursodeoxycholic acid in cholestatic liver disease.

  2023cites this paper
• Untargeted metabonomic analysis of non-alcoholic fatty liver disease with iron overload in rats via UPLC/MS

  2023cites this paper
• Microbiota mitochondria disorders as hubs for early age-related macular degeneration

  2022cites this paper
• Gut microbiota in ischemic stroke: Where we stand and challenges ahead

  2022cites this paper
• An Ultrastructural Perspective on Cell Death.

  2022cites this paper
• Multidimensional analysis and therapeutic development using patient iPSC–derived disease models of Wolfram syndrome

  2022cites this paper
• Bile acid metabolism and signaling, the microbiota, and metabolic disease.

  2022cites this paper
• Redox-Dependent Effects in the Physiopathological Role of Bile Acids

  2021cites this paper
• Genotype-phenotype correlation analysis and therapeutic development using a patient stem cell-derived disease model of Wolfram syndrome

  2021cites this paper
• Quantitative Assessment of Occipital Metabolic and Energetic Changes in Parkinson’s Patients, Using In Vivo 31P MRS-Based Metabolic Imaging at 7T

  2021cites this paper
• Drug-Induced Vanishing Bile Duct Syndrome: From Pathogenesis to Diagnosis and Therapeutics

  2021cites this paper
• Overview of bile acid signaling in the cardiovascular system

  2021cites this paper
• Bile acids as regulatory molecules and potential targets in metabolic diseases.

  2021cites this paper
• Fas, Caspase‐8, and Caspase‐9 pathway‐mediated bile acid‐induced fetal cardiomyocyte apoptosis in intrahepatic cholestasis pregnant rat models

  2021cites this paper
• Current and emerging pharmacological options for the treatment of nonalcoholic steatohepatitis.

  2020cites this paper
• NSA_A_212323 1..9

  2020cites this paper
• Methyl Palmitate—A suitable adjuvant for Sorafenib therapy to reduce in vivo toxicity and to enhance anti‐cancer effects on hepatocellular carcinoma cells

  2020cites this paper
• The effects of ursodeoxycholic acid on sepsis-induced cholestasis management in an animal model

  2020cites this paper
• Ursodeoksikolik Asit’in Farelerde Pentilentetrazol ile Oluşturulan Akut Epileptik Nöbetler Üzerine Etkisinin Araştırılması

  2020cites this paper
• The Experience of Analyzing Biological Activity of Ursodeoxycholic Acid as Part of In Silico Prediction of the Gene Expression Profile

  2020cites this paper
• Ursodeoksikolik Asit’in Farelerde Pentilentetrazol ile Oluşturulan Akut Epileptik Nöbetler Üzerine Etkisinin Investigation of the Effect of Ursodeoxycholic Acid on Pentylenetetrazole-induced Acute Epileptic Seizures in Mice

  2020cites this paper
• The Protective Role of Ursodeoxycholic Acid versus Seleniumon The Methotrexate Hepatotoxicity in Adult Male Albino Rat: Histological, Immunohistochemical and Histomorphmetric Study

  2020cites this paper
• Bio Micro-Nano Technologies of Antioxidants Optimised Their Pharmacological and Cellular Effects, ex vivo, in Pancreatic β-Cells

  2020cites this paper
• Bile acids regulate intestinal antigen presentation and reduce graft-versus-host disease without impairing the graft-versus-leukemia effect

  2020cites this paper
• Reprogramming of Lipid Metabolism as a New Driving Force Behind Tauroursodeoxycholic Acid-Induced Neural Stem Cell Proliferation

  2020cites this paper
• Pediatric Cholestatic Liver Disease: Review of Bile Acid Metabolism and Discussion of Current and Emerging Therapies

  2020cites this paper
• N-acetyl cysteine treatment mitigates biomarkers of oxidative stress in different tissues of bile duct ligated rats

  2020cites this paper
• Nonalcoholic Fatty Liver Disease.

  2020cites this paper
• Ursodeoxycholyl lysophosphatidylethanolamide protects against hepatic ischemia/reperfusion injury via phospholipid metabolism‐mediated mitochondrial quality control

  2020cites this paper
• Tauroursodeoxycholic acid (TUDCA) is neuroprotective in a chronic mouse model of Parkinson’s disease

  2020cites this paper
• Pharmacological interventions for treating intrahepatic cholestasis of pregnancy.

  2020cites this paper
• Intestinal bile acid reabsorption in health and disease

  2019cites this paper
• Tauroursodeoxycholate—Bile Acid with Chaperoning Activity: Molecular and Cellular Effects and Therapeutic Perspectives

  2019cites this paper
• Comprehensive Evaluation of Bile Acid Homeostasis in Human Hepatocyte Co-Culture in the Presence of Troglitazone, Pioglitazone and Acetylsalicylic Acid.

  2019cites this paper
• Intestinal bile acid reabsorption in health and disease

  2019cites this paper
• Cholangiocyte death in ductopenic cholestatic cholangiopathies: Mechanistic basis and emerging therapeutic strategies

  2019cites this paper
• Protein Misfolding Diseases and Therapeutic Approaches.

  2019cites this paper
• Tauroursodeoxycholate protects from glycochenodeoxycholate-induced gene expression changes in perfused rat liver

  2019cites this paper
• Pulmonary endoplasmic reticulum stress—scars, smoke, and suffocation

  2019cites this paper
• Intestinal bile acid reabsorption in health and disease

  2019cites this paper
• UDCA, NorUDCA, and TUDCA in Liver Diseases: A Review of Their Mechanisms of Action and Clinical Applications.

  2019cites this paper
• Mitochondrial dysfunction as a mechanism involved in the pathogenesis of cirrhosis-associated cholemic nephropathy.

  2019cites this paper
• DCA can improve the ACI-induced neurological impairment through negative regulation of Nrf2 signaling pathway.

  2019cites this paper
• Measuring Apoptosis and Necrosis in Cholestatic Liver Injury.

  2019cites this paper
• The effects of ursodeoxycholic acid in the management of sepsis-induced cholestasis in rodents

  2019cites this paper
• Diagnosis, follow-up, and treatment of cystic fibrosis-related liver disease

  2019cites this paper
• The Effects of Cold Preservation Solutions Supplemented with UDCA and α-Lipoic Acid on the Viability and Function of Isolated Human Hepatocytes.

  2019cites this paper
• Measuring the Impact of Bile Acids on the Membrane Order of Primary Hepatocytes and Isolated Mitochondria by Fluorescence Imaging and Spectroscopy.

  2019cites this paper
• The footprints of mitochondrial impairment and cellular energy crisis in the pathogenesis of xenobiotics-induced nephrotoxicity, serum electrolytes imbalance, and Fanconi's syndrome: A comprehensive review.

  2019cites this paper
• Modulation of Cell Fate by Tauroursodeoxycholic Acid: All Paths Lead to Mitochondria

  2018cites this paper
• Tauroursodeoxycholic acid (TUDCA) abolishes chronic high salt‐induced renal injury and inflammation

  2018cites this paper
• Overview of Bile Acids Signaling and Perspective on the Signal of Ursodeoxycholic Acid, the Most Hydrophilic Bile Acid, in the Heart

  2018cites this paper
• Metabolomic Profiling of Bile Acids in an Experimental Model of Prodromal Parkinson’s Disease

  2018cites this paper
• Concentrations of sodium 3α, 7α--dihydroxy-12-oxo 5β cholanate in biological material after its intravenous and intranasal application

  2018cites this paper
• Altered Bile Acid Profile Associates with Cognitive Impairment in Alzheimer’s Disease – An Emerging Role for Gut Microbiome

  2018cites this paper
• Altered Bile Acid Profile in Mild Cognitive Impairment and Alzheimer’s Disease: Relationship to Neuroimaging and CSF Biomarkers

  2018cites this paper
• Ursodeoxycholic acid attenuates 5-fluorouracil-induced mucositis in a rat model.

  2018cites this paper
• Controlled Release of Ursodeoxycholic Acid from Pullulan Acetate Nanoparticles to Modulate Glutamate-Induced Excitotoxicity in PC-12 Cells

  2018cites this paper
• Biochemical Profiling of the Brain and Blood Metabolome in a Mouse Model of Prodromal Parkinson's Disease Reveals Distinct Metabolic Profiles.

  2018cites this paper
• 1 Bile Acid Signaling and Cardioprotection 2

  2018cites this paper
• Effect of Ursodeoxycholic Acid on Pentylenetetrazole Kindling and Kindling Induced Memory Impairment in Rat

  2018cites this paper
• Morphological, Stability, and Hypoglycemic Effects of New Gliclazide-Bile Acid Microcapsules for Type 1 Diabetes Treatment: the Microencapsulation of Anti-diabetics Using a Microcapsule-Stabilizing Bile Acid

  2018cites this paper
• Antiinflammatory and Hepatoprotective Medicinal Herbs as Potential Substitutes for Bear Bile.

  2017cites this paper
• Bile acids and intestinal microbiota in autoimmune cholestatic liver diseases.

  2017cites this paper
• The Emerging Role of Soluble Adenylyl Cyclase in Primary Biliary Cholangitis

  2017cites this paper
• Diagnosis, follow-up and treatment of cystic fibrosis-related liver disease

  2017cites this paper
• Interplay of Endoplasmic Reticulum Stress and Autophagy in Parkinson’s Disease

  2017cites this paper
• Management of Hepatotoxicity Induced by the Use of Olanzapine

  2017cites this paper
• Ursodeoxycholic Acid for the Treatment of Liver Diseases

  2017cites this paper
• Tauroursodeoxycholic Acid Drives Mitochondrial Bioenergetics Toward Neural Stem Cell Proliferation

  2017cites this paper
• Antitumor activity of newly synthesized oxo and ethylidene derivatives of bile acids and their amides and oxazolines

  2017cites this paper
• Tauroursodeoxycholic Acid Enhances Mitochondrial Biogenesis, Neural Stem Cell Pool, and Early Neurogenesis in Adult Rats

  2017cites this paper
• Management of cholestatic disease in 2017

  2017cites this paper
• Salvage Therapies for Autoimmune Hepatitis: A Critical Review

  2017cites this paper
• Role of the bicarbonate-responsive soluble adenylyl cyclase in cholangiocyte apoptosis in primary biliary cholangitis; a new hypothesis.

  2017cites this paper
• Tauroursodeoxycholic Acid Protects Against Mitochondrial Dysfunction and Cell Death via Mitophagy in Human Neuroblastoma Cells

  2017cites this paper
• Herbal medicine Yinchenhaotang protects against α-naphthylisothiocyanate-induced cholestasis in rats

  2017cites this paper
• Bile Acid-Induced Liver Injury in Cholestasis

  2017cites this paper
• Ursodeoxycholic acid suppresses epithelial-mesenchymal transition and cancer stem cell formation by reducing the levels of peroxiredoxin II and reactive oxygen species in pancreatic cancer cells.

  2017cites this paper
• Novel insights into the antioxidant role of tauroursodeoxycholic acid in experimental models of Parkinson's disease.

  2017cites this paper
• Canine Idiopathic Chronic Hepatitis.

  2017cites this paper
• The effect of cholestasis and neuroAID treatment on Bcl-xl gene expression in hippocampus of male rats

  2017cites this paper
• Autoimmune Liver Diseases: Primary Biliary Cholangitis

  2017cites this paper
• Mechanisms of Tauroursodeoxycholate-Mediated Hepatoprotection

  2017cites this paper
• Tauroursodeoxycholic acid improves pre-implantation development of porcine SCNT embryo by endoplasmic reticulum stress inhibition.

  2016cites this paper
• Ursodeoxycholic and deoxycholic acids: Differential effects on intestinal Ca(2+) uptake, apoptosis and autophagy of rat intestine.

  2016cites this paper
• Soluble Adenylyl Cyclase Regulates Bile Salt‐Induced Apoptosis in Human Cholangiocytes

  2016cites this paper
• Implication de "Liver X Receptors" dans la physiopathologie des gonades

  2016cites this paper
• AP-1 Inhibition by SR 11302 Protects Human Hepatoma HepG2 Cells from Bile Acid-Induced Cytotoxicity by Restoring the NOS-3 Expression

  2016cites this paper
• A novel, protective role of ursodeoxycholate in bile-induced pancreatic ductal injury.

  2016cites this paper
• Mitochondria: Major Regulators of Neural Development.

  2016cites this paper
• Cell death mechanisms in human chronic liver diseases: a far cry from clinical applicability.

  2016cites this paper
• CAN URSODEOXYCHOLİC ACİD BE AN ALTERNATİVE OF N-ACETYLCYSTEİN İN ACUTE ACETAMİNOPHEN İNTOXİCATİON ?

  2016cites this paper